Welcome to our dedicated page for AllianzIM U.S. Large Cap Buffer20 Jan ETF news (Ticker: AZBJ), a resource for investors and traders seeking the latest updates and insights on AllianzIM U.S. Large Cap Buffer20 Jan ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AllianzIM U.S. Large Cap Buffer20 Jan ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AllianzIM U.S. Large Cap Buffer20 Jan ETF's position in the market.
Allianz Investment Management LLC has launched the AllianzIM U.S. Large Cap Buffer10 Jan ETF (AZAJ) and AllianzIM U.S. Large Cap Buffer20 Jan ETF (AZBJ), now trading on the NYSE. These ETFs are designed to match the S&P 500 Price Return Index returns up to a stated cap while providing downside risk mitigation through a buffer against the first 10% and 20% of losses for AZAJ and AZBJ, respectively. With an expense ratio of 0.74%, these ETFs aim to help investors navigate ongoing market volatility and low interest rates. The initial outcome period for both ETFs runs from January 1, 2021, to December 31, 2021.
